(9aS)-2-(5-cyclohexyl-1,3-thiazol-2-yl)-9a-methyl-1-oxo-4,6,7,9-tetrahydro-3H-pyrazino[1,2-a]pyrazine-8-carbonitrile
C18H25N5OS — CID 155784077
Data last refreshed: (MolForge compound catalog, from PubChem)
About (9aS)-2-(5-cyclohexyl-1,3-thiazol-2-yl)-9a-methyl-1-oxo-4,6,7,9-tetrahydro-3H-pyrazino[1,2-a]pyrazine-8-carbonitrile
(9aS)-2-(5-cyclohexyl-1,3-thiazol-2-yl)-9a-methyl-1-oxo-4,6,7,9-tetrahydro-3H-pyrazino[1,2-a]pyrazine-8-carbonitrile (PubChem CID 155784077) has the molecular formula C18H25N5OS and a molecular weight of 359.50 g/mol. Its IUPAC name is (9aS)-2-(5-cyclohexyl-1,3-thiazol-2-yl)-9a-methyl-1-oxo-4,6,7,9-tetrahydro-3H-pyrazino[1,2-a]pyrazine-8-carbonitrile.
Molecular Properties
| Compound Name | (9aS)-2-(5-cyclohexyl-1,3-thiazol-2-yl)-9a-methyl-1-oxo-4,6,7,9-tetrahydro-3H-pyrazino[1,2-a]pyrazine-8-carbonitrile |
|---|---|
| PubChem CID | 155784077 |
| Molecular Formula | C18H25N5OS |
| Molecular Weight | 359.50 g/mol |
| Exact Mass | 359.18 |
| IUPAC Name | (9aS)-2-(5-cyclohexyl-1,3-thiazol-2-yl)-9a-methyl-1-oxo-4,6,7,9-tetrahydro-3H-pyrazino[1,2-a]pyrazine-8-carbonitrile |
| SMILES | C[C@@]12CN(C#N)CCN1CCN(c1ncc(C3CCCCC3)s1)C2=O |
| InChI | InChI=1S/C18H25N5OS/c1-18-12-21(13-19)7-8-22(18)9-10-23(16(18)24)17-20-11-15(25-17)14-5-3-2-4-6-14/h11,14H,2-10,12H2,1H3/t18-/m0/s1 |
| InChIKey | UVOJOYNHGFXPSW-SFHVURJKSA-N |
| XLogP | 2.39 |
| TPSA | 63.47 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 359.50 |
| LogP ≤ 5 | 2.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cyanate_/aminonitrile_/thiocyanate', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155784077 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.